D'ANNA, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 1.133
AS - Asia 625
EU - Europa 440
Continente sconosciuto - Info sul continente non disponibili 118
SA - Sud America 96
AF - Africa 12
OC - Oceania 2
Totale 2.426
Nazione #
US - Stati Uniti d'America 1.069
SG - Singapore 316
IT - Italia 183
CN - Cina 94
BR - Brasile 80
RU - Federazione Russa 69
VN - Vietnam 61
HK - Hong Kong 46
BD - Bangladesh 43
DE - Germania 39
FI - Finlandia 30
CA - Canada 27
GB - Regno Unito 26
JP - Giappone 24
MX - Messico 15
NL - Olanda 14
IN - India 13
PL - Polonia 13
SE - Svezia 13
ES - Italia 12
AT - Austria 10
AR - Argentina 8
JM - Giamaica 7
IE - Irlanda 6
UA - Ucraina 6
CR - Costa Rica 5
FR - Francia 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
IQ - Iraq 4
ZA - Sudafrica 4
LT - Lituania 3
PH - Filippine 3
TN - Tunisia 3
TR - Turchia 3
AU - Australia 2
CO - Colombia 2
EC - Ecuador 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
ID - Indonesia 2
KE - Kenya 2
PR - Porto Rico 2
SA - Arabia Saudita 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EG - Egitto 1
GE - Georgia 1
IL - Israele 1
KH - Cambogia 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.308
Città #
Singapore 200
Ashburn 160
San Jose 134
Council Bluffs 68
Rome 45
Hong Kong 44
Beijing 39
Los Angeles 33
New York 29
Santa Clara 29
Denver 25
Tokyo 24
Helsinki 22
Buffalo 20
Ho Chi Minh City 20
Hanoi 19
Munich 19
Naples 17
The Dalles 15
Dallas 14
Milan 13
Engelhard 12
São Paulo 12
Washington 12
Orem 10
Chicago 9
Mexico City 9
Brooklyn 8
Poplar 8
Chandler 7
Montreal 7
North Bergen 7
Atlanta 6
Nuremberg 6
Philadelphia 6
Phoenix 6
St. George 6
Toronto 6
Warsaw 6
Brasília 5
Creede 5
Frankfurt am Main 5
Kingston 5
Lappeenranta 5
London 5
Palermo 5
Redondo Beach 5
Vienna 5
Barcelona 4
Calgary 4
Chennai 4
Dublin 4
Houston 4
Manchester 4
Messina 4
Moscow 4
Queens 4
San José 4
Stockholm 4
Wylie 4
Amsterdam 3
Bergamo 3
Charlotte 3
Colorado Springs 3
Da Nang 3
Fresno 3
Guangzhou 3
Riverside 3
San Francisco 3
Turku 3
Ancona 2
Ann Arbor 2
Athens 2
Baghdad 2
Biên Hòa 2
Boardman 2
Canoas 2
Cassino 2
Catanzaro 2
Caxias do Sul 2
City of London 2
Collinsville 2
Conway 2
Florence 2
Fort Mill 2
Gdansk 2
Gdynia 2
Guatemala City 2
Jacksonville 2
Johannesburg 2
Lake City 2
Las Vegas 2
Louisville 2
Maceió 2
Medford 2
Miami 2
Milwaukee 2
Mumbai 2
North Kansas City 2
Paris 2
Totale 1.315
Nome #
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 171
Comprehensive insight of epidemiological and virological features underlying patients with HBV/HDV co-infection drug-naïve or treated with the recently approved entry inhibitor 139
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation 138
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 125
SARS-CoV-2 Mutations and Variants May Muddle the Sensitivity of COVID-19 Diagnostic Assays 124
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses 108
Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response 106
Hepatitis delta virus (HDV) infection : frequency and outcome in persons living with HIV (PLWH). Data from the ICONA (Italian cohort of naïve for antiretrovirals) cohort 105
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 102
Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles 101
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 100
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 98
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy 94
Heterogeneity in the diagnostic sensitivities of HDV RNA quantification assays used in clinical practice in Italy: data from the first national quality control multicenter study. 89
Heterogeneity in the diagnostic performances of HDV RNA quantification assays used in clinical practice in Italy: results from a national quality control multicenter study. 82
PREVALENCE AND OUTCOME OF HEPATITIS DELTA VIRUS (HDV) INFECTION AMONG PERSONS LIVING WITH HIV (PLWH) IN ITALY: THE DELTA-ICONA STUDY OC 150 82
Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks 79
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. 77
Different diagnostic performances of HDV RNA quantification assays used in clinical practicein Italy: results from a national quality control multicenter study. 72
Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study 65
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. 49
HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA 49
Kinetics of occult hepatitis B infection in people with HIV switching from HBV-active ART to long-acting cabotegravir/rilpivirine 42
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. 38
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity 36
HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential. 34
Caratterizzazione intraepatica dell'attività di HDV sostenuta dall'integrazione di HBV al baseline e sotto trattamento. 31
Intra-hepatic HDV replicative activity can be sustained by HBsAg production from HBV-DNA integration and can modulate virological response to bulevirtide 30
HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D 29
Chronic HDV Infection Shows Higher HBsAg Isoform Levels than HBV Infection, Paralleling HDV Replicative Activity 28
null 3
Totale 2.426
Categoria #
all - tutte 10.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 0 0 0 10 1 0 4 1 0 4
2022/202329 1 2 0 2 9 6 6 0 1 0 2 0
2023/202486 2 0 1 5 1 4 1 1 7 57 2 5
2024/2025411 6 83 39 18 11 48 48 22 31 18 50 37
2025/20261.269 110 45 92 117 113 44 128 132 159 154 100 75
2026/2027611 107 80 216 208 0 0 0 0 0 0 0 0
Totale 2.426